BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aninat C, Seguin P, Descheemaeker PN, Morel F, Malledant Y, Guillouzo A. Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med 2008;36:848-54. [PMID: 18431272 DOI: 10.1097/CCM.0B013E31816532BE] [Cited by in Crossref: 64] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Daniel Y, Lelou E, Aninat C, Corlu A, Cabillic F. Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells. Cancers (Basel) 2021;13:1973. [PMID: 33923958 DOI: 10.3390/cancers13081973] [Reference Citation Analysis]
2 Gröger M, Rennert K, Giszas B, Weiß E, Dinger J, Funke H, Kiehntopf M, Peters FT, Lupp A, Bauer M, Claus RA, Huber O, Mosig AS. Monocyte-induced recovery of inflammation-associated hepatocellular dysfunction in a biochip-based human liver model. Sci Rep 2016;6:21868. [PMID: 26902749 DOI: 10.1038/srep21868] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
3 Bock C, Vogt B, Mattecka S, Yapici G, Brunner P, Fimpel S, Unger JK, Sheriff A. C-Reactive Protein Causes Blood Pressure Drop in Rabbits and Induces Intracellular Calcium Signaling. Front Immunol 2020;11:1978. [PMID: 32983135 DOI: 10.3389/fimmu.2020.01978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rearte B, Landoni V, Laborde E, Fernández G, Isturiz M. Differential effects of glucocorticoids in the establishment and maintenance of endotoxin tolerance. Clin Exp Immunol 2010;159:208-16. [PMID: 19912256 DOI: 10.1111/j.1365-2249.2009.04052.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
5 Selim SA, El-Baset SAA, Kattaia AAA, Askar EM, Elkader EA. Bone marrow-derived mesenchymal stem cells ameliorate liver injury in a rat model of sepsis by activating Nrf2 signaling. Histochem Cell Biol 2019;151:249-62. [PMID: 30250973 DOI: 10.1007/s00418-018-1731-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Russell JA. Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care. 2011;15:226. [PMID: 21892977 DOI: 10.1186/cc8224] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 8.7] [Reference Citation Analysis]
7 Massart N, Mansour A, Ross JT, Ecoffey C, Aninat C, Verhoye JP, Launey Y, Tadie JM, Auffret V, Flecher E, Nesseler N. Epinephrine administration in venoarterial extracorporeal membrane oxygenation patients is associated with mortality: a retrospective cohort study. ESC Heart Fail 2021;8:2899-906. [PMID: 33963814 DOI: 10.1002/ehf2.13370] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Lin JC, Peng YJ, Wang SY, Young TH, Salter DM, Lee HS. Role of the sympathetic nervous system in carbon tetrachloride-induced hepatotoxicity and systemic inflammation. PLoS One 2015;10:e0121365. [PMID: 25799095 DOI: 10.1371/journal.pone.0121365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
9 Febvre-James M, Lecureur V, Fardel O. Potent repression of C-reactive protein (CRP) expression by the JAK1/2 inhibitor ruxolitinib in inflammatory human hepatocytes. Inflamm Res 2020;69:51-62. [PMID: 31654094 DOI: 10.1007/s00011-019-01293-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
10 Ji XJ, Hao JW, Li GL, Dong N, Wang XQ, Zhou M, Zhang QH, Yao YM. Exendin-4 Exacerbates Burn-Induced Morbidity in Mice by Activation of the Sympathetic Nervous System. Mediators Inflamm 2019;2019:2750528. [PMID: 30800001 DOI: 10.1155/2019/2750528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Schöniger-Hekele M, Madl C. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011;37:1302-1310. [PMID: 21647720 DOI: 10.1007/s00134-011-2248-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 7.5] [Reference Citation Analysis]
12 Fan J, He M, Wang CJ, Zhang M. Gadolinium Chloride Inhibits the Production of Liver Interleukin-27 and Mitigates Liver Injury in the CLP Mouse Model. Mediators Inflamm 2021;2021:2605973. [PMID: 33564275 DOI: 10.1155/2021/2605973] [Reference Citation Analysis]
13 Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med. 2009;35:1397-1405. [PMID: 19506833 DOI: 10.1007/s00134-009-1508-2] [Cited by in Crossref: 126] [Cited by in F6Publishing: 99] [Article Influence: 10.5] [Reference Citation Analysis]
14 Savalle M, Gillaizeau F, Maruani G, Puymirat E, Bellenfant F, Houillier P, Fagon J, Faisy C. Assessment of body cell mass at bedside in critically ill patients. American Journal of Physiology-Endocrinology and Metabolism 2012;303:E389-96. [DOI: 10.1152/ajpendo.00502.2011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
15 Coppeta JR, Mescher MJ, Isenberg BC, Spencer AJ, Kim ES, Lever AR, Mulhern TJ, Prantil-Baun R, Comolli JC, Borenstein JT. A portable and reconfigurable multi-organ platform for drug development with onboard microfluidic flow control. Lab Chip 2016;17:134-44. [PMID: 27901159 DOI: 10.1039/c6lc01236a] [Cited by in Crossref: 63] [Cited by in F6Publishing: 20] [Article Influence: 21.0] [Reference Citation Analysis]
16 Simon F, Giudici R, Scheuerle A, Gröger M, Asfar P, Vogt JA, Wachter U, Ploner F, Georgieff M, Möller P, Laporte R, Radermacher P, Calzia E, Hauser B. Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Crit Care 2009;13:R113. [PMID: 19591694 DOI: 10.1186/cc7959] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
17 Yang X, Lou J, Shan W, Ding J, Jin Z, Hu Y, Du Q, Liao Q, Xie R, Xu J. Pathophysiologic Role of Neurotransmitters in Digestive Diseases. Front Physiol 2021;12:567650. [PMID: 34194334 DOI: 10.3389/fphys.2021.567650] [Reference Citation Analysis]
18 Ooka M, Lynch C, Xia M. Application of In Vitro Metabolism Activation in High-Throughput Screening. Int J Mol Sci 2020;21:E8182. [PMID: 33142951 DOI: 10.3390/ijms21218182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol. 2017;14:55-66. [PMID: 27924081 DOI: 10.1038/nrgastro.2016.168] [Cited by in Crossref: 168] [Cited by in F6Publishing: 156] [Article Influence: 33.6] [Reference Citation Analysis]
20 Lee J, Kothari R, Ladapo JA, Scott DJ, Celi LA. Interrogating a clinical database to study treatment of hypotension in the critically ill. BMJ Open. 2012;2. [PMID: 22685222 DOI: 10.1136/bmjopen-2012-000916] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
21 Mathur N, Mehdi SF, Anipindi M, Aziz M, Khan SA, Kondakindi H, Lowell B, Wang P, Roth J. Ghrelin as an Anti-Sepsis Peptide: Review. Front Immunol 2020;11:610363. [PMID: 33584688 DOI: 10.3389/fimmu.2020.610363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Fuhrmann V, Jäger B, Zubkova A, Drolz A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr. 2010;122:129-139. [PMID: 20361374 DOI: 10.1007/s00508-010-1357-6] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
23 Hartemink KJ, Groeneveld AB. Vasopressors and inotropes in the treatment of human septic shock: effect on innate immunity? Inflammation 2012;35:206-13. [PMID: 21347606 DOI: 10.1007/s10753-011-9306-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
24 Nesseler N, Launey Y, Aninat C, Morel F, Mallédant Y, Seguin P. Clinical review: The liver in sepsis. Crit Care 2012;16:235. [PMID: 23134597 DOI: 10.1186/cc11381] [Cited by in Crossref: 123] [Cited by in F6Publishing: 118] [Article Influence: 13.7] [Reference Citation Analysis]